Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03794609 · ClinicalTrials.gov registry record
Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.
A clinical trial, sponsored by Pfizer.
- Terminated
- Registry status
- 315
- Enrollment target
NCT03794609 is a clinical trial that was terminated before completion, run by Pfizer. The registered enrollment target is 315 participants.
The verdict
NCT03794609 was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- 315 participants
- Enrollment target
Study Summary
This is a registry study in children with achondroplasia, age 0-10 years, to be conducted at multiple clinical centers in several countries. Information collected will include in anthropometric characteristics, related symptoms, tests, \& treatments Children's information will be collected in the registry for a maximum of 5 years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2018-06-15 |
| Est. Completion | 2023-01-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03794609
The ClinicalTrials.gov registry entry for NCT03794609 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03794609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03794609 about?
NCT03794609 is a clinical study titled "Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.". This is a registry study in children with achondroplasia, age 0-10 years, to be conducted at multiple clinical centers in several countries. Information collected will include in anthropometric characteristics, related symptoms, tests, \& treatments Children's information will be collected in the r...
What is the current status of trial NCT03794609?
This trial is currently terminated. The enrollment target is 315 participants. The study started on 2018-06-15. Estimated completion is 2023-01-13.
Who is sponsoring clinical trial NCT03794609?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.